Bottom line
Is PFSLX a good fund? The bottom line
PFSLX is a managed large blend mutual fund from Paradigm.
Its expense ratio is 1.16% — about $116 a year on every $10,000 invested, more expensive than 72% of large blend funds we track.
It returned +13.3% over one year, +10.1% a year over five years, +13.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $283 million in net assets and 44 holdings, its largest position is Lumentum Holdings Inc. (7.5%) and the top 10 make up 50.3% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (1.16%)
- Concentrated: top 10 holdings are 50.3% of assets
Updated Nov 19, 2026
What PFSLX invests in
? The Paradigm Select Fund (the Select Fund or the Fund) seeks long-term capital appreciation.
The Select Fund invests primarily in the common stocks of companies with market capitalizations between $500 million and $10 billion at the time of purchase that the Advisor believes have the potential for capital appreciation. The Fund may be overweight in certain sectors at various times. Securities are sold when they have realized their anticipated value or if new investment opportunities with higher expected returns are acquired.
From the fund's prospectus (filed Apr 29, 2026).
PFSLX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PFSLX | +13.3% | +10.1% | +13.1% |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What PFSLX costs
On a $10,000 investment, PFSLX's 1.16% expense ratio costs about $116 a year. The prospectus estimates $1,409 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
PFSLX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Lumentum Holdings Inc. | 7.45% |
| 2 | Marvell Technology Group Ltd. | 7.29% |
| 3 | Teradyne, Inc. | 5.74% |
| 4 | Natera, Inc. | 5.69% |
| 5 | Goldman Sachs Trust - Goldman Sachs Financial Square Government Fund Institutional Class | 4.88% |
| 6 | EMCOR Group, Inc. | 4.51% |
| 7 | Globus Medical, Inc. | 3.86% |
| 8 | Kulicke & Soffa Industries Inc. | 3.78% |
| 9 | Revvity, Inc. | 3.71% |
| 10 | Carpenter Technology Corporation | 3.39% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 50.3% of the fund. See all top 25 holdings and asset mix →